Hyundai Pharm (004310)

Currency in KRW
3,840
-65(-1.66%)
Closed·
004310 Scorecard
Full Analysis
Stock has taken a big hit over the last week
004310 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3,8403,920
52 wk Range
2,9956,620
Key Statistics
Bid/Ask
3,840.00 / 3,855.00
Prev. Close
3,905
Open
3,870
Day's Range
3,840-3,920
52 wk Range
2,995-6,620
Volume
379.23K
Average Volume (3m)
1.66M
1-Year Change
-25.62%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
004310 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Hyundai Pharm Company Profile

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive system, endocrine system, expectorants, eye tonic and vitamins, gynaecolog antifungals, gynaecologic antiseptics, hemostatics, labour inhibitors, leukotriene modulator, narcotic analgesics, NSAIDs, oestrogens, ophthalmic products, OTH.sex horm and similar, SERMS, systemic hormonal contraceptives, urogenital system depilatory, uterotonic products, various alimentary tract and metabolism products, vitamins, acne, allergy, alopecia treatment, analgesics and anti-inflammatory, anemia, antimicrobial and antivirus, arthritis, contraceptives, dermatological agent, diagnostic reagent, gastrointestinal disorder and digestant, lip care, nutrition, ophthalmic product, respiratory, urogenital system, wound healing, and others. Hyundai Pharmaceutical Co., Ltd. was founded in 1965 and is headquartered in Seoul, South Korea.

Employees
393

Compare 004310 to Peers and Sector

Metrics to compare
004310
Peers
Sector
Relationship
P/E Ratio
0.0x−4.4x−0.5x
PEG Ratio
0.000.030.00
Price/Book
0.0x1.1x2.6x
Price / LTM Sales
0.0x0.9x3.2x
Upside (Analyst Target)
0.0%0.0%42.0%
Fair Value Upside
Unlock10.7%6.6%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 60.34%
Dividend Yield
0.78%
Industry Median 0.93%
Annualised payout
30.00
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 14, 2023
EPS / Forecast
60.79 / --
Revenue / Forecast
38.89B / --
EPS Revisions
Last 90 days

004310 Income Statement

FAQ

What Stock Exchange Does Hyundai Pharm Trade On?

Hyundai Pharm is listed and trades on the Seoul Stock Exchange stock exchange.

What Is the Stock Symbol for Hyundai Pharm?

The stock symbol for Hyundai Pharm is "004310."

What Is the Hyundai Pharm Market Cap?

As of today, Hyundai Pharm market cap is 108.08B.

What Is Hyundai Pharm's Earnings Per Share (TTM)?

The Hyundai Pharm EPS (TTM) is 60.34.

From a Technical Analysis Perspective, Is 004310 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Hyundai Pharm Stock Split?

Hyundai Pharm has split 6 times.

How Many Employees Does Hyundai Pharm Have?

Hyundai Pharm has 393 employees.

What is the current trading status of Hyundai Pharm (004310)?

As of 30 Jul 2025, Hyundai Pharm (004310) is trading at a price of 3,840.00, with a previous close of 3,905.00. The stock has fluctuated within a day range of 3,840.00 to 3,920.00, while its 52-week range spans from 2,995.00 to 6,620.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.